SCHEMBL13870941

SCHEMBL13870941

COc1cccc(-c2ccc3c(OC)c(OC)c(OC)cc3n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.52
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 3/20 0.52
PDGFRB P09619 2/20 0.51
PDGFRA P16234 1/20 0.51
KIT P10721 1/20 0.50
KDR P35968 1/20 0.50
MAP4K4 O95819 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TOP1 P11387 1/20 0.44
TDO2 P48775 1/20 0.44
FYN P06241 1/20 0.43
MAPT P10636 3/20 0.43
THRB P10828 1/20 0.43
RAB9A P51151 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870933 0.86 ALDH1A1 (0.48) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL16488123 0.85 MAP4K4 (0.46) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL1337819 0.85 KDM4E (0.54) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL13870924 0.83 SMN1; SMN2 (0.66) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL16487826 0.83 MAP4K4 (0.44) SMN1; SMN2KDM4EALDH1A1PDGFRBKIT
SCHEMBL13870935 0.81 PDGFRB (0.61) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL13870944 0.80 KATNA1 (0.44) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL13870932 0.79 MAOA (0.44) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL1337875 0.78 PDGFRB (0.51) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA
SCHEMBL16487812 0.78 SMN1; SMN2 (0.55) SMN1; SMN2KDM4EALDH1A1PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 SMN1; SMN2 4169/4885KDM4E 2874/4885ALDH1A1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.